Apart from ZLM-7, 2-Methoxy-5 ((3,4,5-trimethosyphenyl) seleninyl) phenol (SQ) is another synthesized structural analogue of CA-4 with a proven cell-cycle blocking effect that has been investigated to be a potential treatment for breast cancer. Here, CA4 is linked to breast carcinoma.